Analytical Bioassays Reimagined
Using Predictive AIs and Imaging to identify and leverage digital biomarkers to uncover insights from the analysis of previously inaccessible "big data".
ViQi doesn't just replace the manual data analysis of current assays. Our cross-disciplinary team works with you to develop a specific wet lab protocol that takes full advantage of machine learning to shorten assay development timelines, increase throughput, decrease time-to-answer, and improve assay sensitivity and precision.
Leveraging AIs and Imaging to Fully Utilize the Potential of
End-to-End Automation
By simplifying bioassays, we help you bring innovations to market faster, making a real-world impact with precision and purpose.
Advanced, Custom Assays–Made Easy
Customized, AI-Powered Assays: Unlike companies who offer off-the-shelf solutions, ViQi excels at custom-built, AI-driven assays tailored to your specific scientific needs. Whether your current bioassay needs optimizing, or one does not yet exist, ViQi's platform develops customized solutions for faster and more precise results.
End-to-End Integration:
Compliance-Driven Innovation
ViQi goes beyond simply creating assays. Our platform seamlessly integrates with your existing workflows, delivering elegant, AI-powered solutions that bridge life sciences, computer science, and imaging. Every custom solution is designed with regulatory compliance and operational efficiency in mind and built on top of FDA Class 1 MDDS designated and ISO27001 certified platform.
Speed and Efficiency
Biopharma process development and biomanufacturing companies can shorten development timelines and improve operational efficiency through advanced data analytics. ViQi uses tailored machine learning to analyze data from automated imagers to dramatically reduce development timelines and increase throughput of cell-based bioassays.
What Our Customers are Saying
Some of Our Trusted Partners
* Top image captured using the Araceli Endeavor® platform
